mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
-0.24 |
0.2 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.2 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |